The Patent Finder

P.N. Gerolymatos S.A.

Also on record
Records under this name other than patents P.N. Gerolymatos S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to P.N. Gerolymatos S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,030,136Use of phanquinone for the treatment or prevention of memory impairment
Formerly held
Lapsed on the fee record
Ended Apr 18, 2014 · USPTO record
Lapsed on the fee recordEnded Apr 18, 2014USPTO record
US 7,629,354Use of phanquinone for the treatment of Alzheimer's disease
Formerly held
Lapsed on the fee record
Ended Dec 8, 2013 · USPTO record
Lapsed on the fee recordEnded Dec 8, 2013USPTO record
US 6,670,369Use of phanquinone for the treatment of alzheimer's disease
Formerly held
Lapsed on the fee record
Ended Dec 30, 2011 · USPTO record
Lapsed on the fee recordEnded Dec 30, 2011USPTO record
US 6,548,554Ionic aqueous composition containing levomenthol
Lapsed on the fee record
Ended Apr 15, 2011 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2011USPTO record
US 6,652,877Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
Formerly held
Surrendered on reissue
Surrendered on reissue Apr 11, 2006 · USPTO record
Surrendered on reissueSurrendered on reissue Apr 11, 2006USPTO record
US 5,980,914Clioquinol for the treatment of Parkinson's disease
Formerly held
Term ended
Term ended no later than Nov 9, 2019 · Low confidence
Term endedTerm ended no later than Nov 9, 2019Low confidence
US 5,994,323Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
Formerly held
Term ended
Term ended no later than Nov 30, 2019 · Low confidence
Term endedTerm ended no later than Nov 30, 2019Low confidence
US 6,001,852Clioquinol for the treatment of Alzheimer's disease
Formerly held
Term ended
Term ended no later than Dec 14, 2019 · Low confidence
Term endedTerm ended no later than Dec 14, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited